It also discusses the targeted therapies for related aberrations, aiming to provide a comprehensive understanding of the dynamic interplay of PIK3R1 in cancer, thereby advancing precision medicine and the development of targeted interventions. This evidence concerns the gene PIK3R1 and cancer.